(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) jumped 5.25% to $34.91 at 10:06 EST on Thursday, after five consecutive sessions in a row of losses. NASDAQ is dropping 1.15% to $14,340.25, after two consecutive sessions in a row of losses. This seems, up until now, an all-around bearish trend exchanging session today.

Castle Biosciences’s last close was $33.17, 69.2% below its 52-week high of $107.69.


Today’s last reported volume for Castle Biosciences is 4915 which is 97.9% below its average volume of 234338.

Castle Biosciences’s Sales

Castle Biosciences’s sales growth is 53.2% for the present quarter and 39.2% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 73.9% and a negative 69.6%, respectively.

Castle Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 31%, now sitting on 68.04M for the twelve trailing months.


Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.87%, a positive 0.15%, and a positive 3.59%, respectively.

Castle Biosciences’s highest amplitude of average volatility was 4.87% (last week), 3.71% (last month), and 3.59% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Castle Biosciences’s stock is considered to be overbought (>=80).

Castle Biosciences’s Stock Yearly Top and Bottom Value

Castle Biosciences’s stock is valued at $34.91 at 10:06 EST, way below its 52-week low of $39.34.

Castle Biosciences’s Moving Average

Castle Biosciences’s worth is way under its 50-day moving average of $54.83 and way under its 200-day moving average of $64.52.

More news about Castle Biosciences (CSTL).


Please enter your comment!
Please enter your name here